Each single-dose Zurnai autoinjector delivers a dose of 1.5mg nalmefene (base) in 0.5mL. The Food and Drug Administration (FDA) has approved Zurnai ™, the first nalmefene HCl autoinjector for ...

Astute Analytica has released a comprehensive report titled North America & Europe Nalmefene Hydrochloride Market – Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced positive topline results from the company’s Phase 3 multi-center trial evaluating the ...

Nalmefene hydrochloride injection is an opioid antagonist indicated for the complete or partial reversal of opioid drug effects, including respiratory depression, induced by either natural or ...

is the first nalmefene hydrochloride auto-injector for known or suspected opioid overdose in people aged 12 years and older. Medscape Medical News, August 08, 2024 Alert FDA Approves Vorasidenib ...

is the first nalmefene hydrochloride auto-injector for known or suspected opioid overdose in people aged 12 years and older. Medscape Medical News, August 08, 2024 Does Headache Surgery Really Work?

(HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the largest cardio-cerebral vascular ("CCV") drug franchise in China's prescription market, announced ...